Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors

Area of Science:

• Biochemistry
• Enzymology
• Molecular Biology

Background:

• Human 5 alpha-reductase exists as two main isoforms, type 1 and type 2, which play crucial roles in steroid metabolism.
• Understanding the distinct properties and inhibition profiles of these isoforms is vital for developing targeted therapies.

Purpose of the Study:

• To independently express and characterize human 5 alpha-reductase type 1 and type 2 isoforms.
• To investigate the selectivity of various inhibitors against these isoforms.
• To elucidate the kinetic parameters and pH optima of the recombinant enzymes.

Main Methods:

• Baculovirus-directed insect cell expression system for recombinant protein production.
• Enzyme kinetics assays to determine catalytic properties and inhibition constants (Km, Ki).
• pH optimum determination for both 5 alpha-reductase isoforms.

Main Results:

• Recombinant human 5 alpha-reductase type 1 and type 2 isoforms were successfully expressed with consistent kinetic parameters.
• Type 1 isoform exhibited a neutral pH optimum (6-8), while type 2 preferred acidic conditions (5-6).
• Finasteride and turosteride selectively inhibited type 2, whereas 4-MA and Serenoa repens extract inhibited both isoforms with varying mechanisms.

Conclusions:

• Distinct biochemical properties of 5 alpha-reductase isoforms were confirmed through recombinant expression.
• Lipid components, like those in Serenoa repens extract, may modulate enzyme activity by altering the membrane environment.
• The findings provide a basis for developing isoform-specific inhibitors for therapeutic applications.